Wednesday, February 16, 2022 2:51:18 PM
Recent HOOK News
- HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 03/22/2024 11:01:00 AM
- HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference • GlobeNewswire Inc. • 03/06/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:30:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:12:08 PM
- HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs • GlobeNewswire Inc. • 01/29/2024 01:01:00 PM
- HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization • GlobeNewswire Inc. • 01/16/2024 12:01:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/05/2024 05:15:14 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 12:33:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 12:06:13 PM
- HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences • GlobeNewswire Inc. • 12/21/2023 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:46:37 PM
- HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus • GlobeNewswire Inc. • 11/20/2023 12:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 12:10:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 12:05:09 PM
- HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 11/09/2023 12:01:00 PM
- HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023 • GlobeNewswire Inc. • 11/03/2023 04:01:00 PM
- HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023 • GlobeNewswire Inc. • 11/02/2023 08:01:00 PM
- HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023 • GlobeNewswire Inc. • 10/22/2023 10:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:05:45 PM
- HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences • GlobeNewswire Inc. • 10/18/2023 11:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 12:47:15 PM
- HOOKIPA Announces Executive Leadership Change • GlobeNewswire Inc. • 09/13/2023 12:45:00 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 09/12/2023 12:01:23 PM
- HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/12/2023 11:01:00 AM
- HOOKIPA Pharma to participate in upcoming investor conferences in September • GlobeNewswire Inc. • 09/06/2023 11:01:00 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM